Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 16 studies | 51% ± 16% | |
glutamatergic neuron | 9 studies | 36% ± 16% | |
GABAergic neuron | 8 studies | 34% ± 9% | |
astrocyte | 7 studies | 29% ± 17% | |
interneuron | 6 studies | 33% ± 19% | |
neuron | 5 studies | 44% ± 17% | |
retinal cone cell | 4 studies | 35% ± 7% | |
endothelial cell | 3 studies | 33% ± 17% | |
GABAergic interneuron | 3 studies | 25% ± 5% | |
retinal ganglion cell | 3 studies | 50% ± 19% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 15 studies | 32% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 95% | 518.75 | 2517 / 2642 | 54% | 1.50 | 379 / 705 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.59 | 1 / 1 |
bladder | 67% | 213.10 | 14 / 21 | 21% | 0.95 | 108 / 504 |
intestine | 55% | 45.92 | 536 / 966 | 9% | 0.23 | 48 / 527 |
muscle | 57% | 97.90 | 457 / 803 | 0% | 0 | 0 / 0 |
lung | 19% | 10.44 | 111 / 578 | 27% | 1.36 | 307 / 1155 |
stomach | 17% | 9.45 | 60 / 359 | 15% | 0.42 | 42 / 286 |
adrenal gland | 5% | 3.48 | 13 / 258 | 26% | 1.06 | 59 / 230 |
esophagus | 6% | 2.74 | 83 / 1445 | 20% | 0.75 | 36 / 183 |
skin | 3% | 1.48 | 61 / 1809 | 20% | 0.85 | 95 / 472 |
pancreas | 0% | 0.10 | 1 / 328 | 18% | 0.43 | 32 / 178 |
ovary | 1% | 0.50 | 2 / 180 | 13% | 0.26 | 57 / 430 |
uterus | 0% | 0 | 0 / 170 | 11% | 0.46 | 52 / 459 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.23 | 4 / 45 |
prostate | 7% | 7.30 | 18 / 245 | 1% | 0.02 | 7 / 502 |
breast | 0% | 0 | 0 / 459 | 7% | 0.38 | 77 / 1118 |
kidney | 1% | 0.60 | 1 / 89 | 3% | 0.10 | 28 / 901 |
peripheral blood | 4% | 1.76 | 35 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 4% | 0.12 | 3 / 80 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.09 | 1 / 29 |
liver | 0% | 0 | 0 / 226 | 2% | 0.05 | 9 / 406 |
blood vessel | 2% | 0.71 | 23 / 1335 | 0% | 0 | 0 / 0 |
thymus | 1% | 0.46 | 8 / 653 | 0% | 0.02 | 3 / 605 |
spleen | 2% | 0.78 | 4 / 241 | 0% | 0 | 0 / 0 |
adipose | 0% | 0.15 | 5 / 1204 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0050819 | Biological process | negative regulation of coagulation |
GO_0015015 | Biological process | heparan sulfate proteoglycan biosynthetic process, enzymatic modification |
GO_0046596 | Biological process | regulation of viral entry into host cell |
GO_0006477 | Biological process | protein sulfation |
GO_0000139 | Cellular component | Golgi membrane |
GO_0016020 | Cellular component | membrane |
GO_0008467 | Molecular function | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity |
GO_0050656 | Molecular function | 3'-phosphoadenosine 5'-phosphosulfate binding |
GO_0005515 | Molecular function | protein binding |
Gene name | HS3ST5 |
Protein name | Heparan sulfate glucosamine 3-O-sulfotransferase 5 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 5) (3-OST-5) (Heparan sulfate 3-O-sulfotransferase 5) (h3-OST-5) |
Synonyms | 3OST5 HS3OST5 |
Description | FUNCTION: Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) to catalyze the transfer of a sulfo group to position 3 of glucosamine residues in heparan. Catalyzes the rate limiting step in the biosynthesis of heparan sulfate (HSact). This modification is a crucial step in the biosynthesis of anticoagulant heparan sulfate as it completes the structure of the antithrombin pentasaccharide binding site. Also generates GlcUA-GlcNS or IdoUA-GlcNS and IdoUA2S-GlcNH2. The substrate-specific O-sulfation generates an enzyme-modified heparan sulfate which acts as a binding receptor to Herpes simplex virus-1 (HSV-1) and permits its entry. . |
Accessions | Q8IZT8 ENST00000312719.10 |